The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,516.00
Bid: 12,304.00
Ask: 12,600.00
Change: 0.00 (0.00%)
Spread: 296.00 (2.406%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,516.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK rolls out AstraZeneca vaccine, touts British science triumph

Mon, 04th Jan 2021 07:57

* UK first to roll out AstraZeneca

* UK has vaccinated 1 million people

* Oxford/AstraZeneca shot can be stored in fridge

* China and Russia vaccinate their populations
(Adds first patient to get the vaccine)

By William James and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - Britain began vaccinating its
population on Monday with the COVID-19 shot developed by Oxford
University and AstraZeneca, touting its position as the
first Western country to roll out an inoculation programme
against the novel coronavirus.

Britain, which is rushing to vaccinate its population faster
than the United States and the rest of Europe in a bid to put
the pandemic behind it, is the first country to roll out the
Oxford/AstraZeneca shot.

It last year rolled out the Pfizer and Germany's
BioNTech vaccine. Dialysis patient Brian Pinker, 82, was the
first to get the Oxford/AstraZeneca shot at 0730 GMT at Oxford
University Hospital.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford,"
Pinker, a retired maintenance manager who has been having
dialysis for kidney disease, said.

He said he was looking forward to celebrating his 48th
wedding anniversary with wife Shirley in February.

"The nurses, doctors and staff today have all been
brilliant," he said.

Britain has put more than 1 million COVID-19 vaccines into
arms already - more than the rest of Europe put together, Health
Secretary Matt Hancock said, adding that the roll out of the
Oxford/AstraZeneca vaccine was a triumph.

"That's a triumph of British science that we've managed to
get where we are," Hancock told Sky. "Right at the start, we saw
that the vaccine was the only way out long term."

Prime Minister Boris Johnson’s government has secured 100
million doses of the Oxford/AstraZeneca vaccine which can be
stored at fridge temperatures between two to eight degrees,
making it easier to distribute than the Pfizer shot.

Six hospitals in England are administering the first of
around 530,000 doses Britain has ready. The programme will be
expanded to hundreds of other British sites in the coming days,
and the government hopes it will deliver tens of millions of
doses within months.
(Writing by William James and Guy Faulconbridge; Editing by
Susan Fenton, Kate Holton and Raissa Kasolowsky)

More News
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.